GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹14 Cr | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr |
What is the latest Sundry Debtors ratio of GENNEX LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹9.42 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹7.66 Cr |
How is Sundry Debtors of GENNEX LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -20.49 | |
| Mar2024 | ₹18 Cr | 89.14 | |
| Mar2023 | ₹9.42 Cr | -16.76 | |
| Mar2022 | ₹11 Cr | 47.75 | |
| Mar2021 | ₹7.66 Cr | - | |
Compare Sundry Debtors of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹248.0 Cr | 8.9% | -0.4% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 8.9% |
-0.4% |
-23% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses